Spruce Biosciences Inc (NASDAQ:SPRB) shares, rose in value on Wednesday, April 16, with the stock price down by -6.82% to the previous day’s close as strong demand from buyers drove the stock to $0.12.
Actively observing the price movement in the last trading, the stock closed the session at $0.13, falling within a range of $0.1177 and $0.1382. The value of beta (5-year monthly) was 2.39. Referring to stock’s 52-week performance, its high was $0.87, and the low was $0.13. On the whole, SPRB has fluctuated by -62.24% over the past month.
With the market capitalization of Spruce Biosciences Inc currently standing at about $5.08 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Apr-14.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SPRB’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of SPRB currently trading nearly -56.73% and -63.91% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 19.06, while the 7-day volatility ratio is showing 21.28% which for the 30-day chart, stands at 12.88%. Furthermore, Spruce Biosciences Inc (SPRB)’s beta value is 2.56, and its average true range (ATR) is 0.04.
A comparison of Spruce Biosciences Inc (SPRB) with its peers suggests the former has fared considerably weaker in the market. SPRB showed an intraday change of -6.82% in last session, and over the past year, it shrunk by -82.57%%.
Data on historical trading for Spruce Biosciences Inc (NASDAQ:SPRB) indicates that the trading volumes over the past 10 days have averaged 3.8 and over the past 3 months, they’ve averaged 799.92K. According to company’s latest data on outstanding shares, there are 42.23 million shares outstanding.
Nearly 30.86% of Spruce Biosciences Inc’s shares belong to company insiders and institutional investors own 23.54% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.14 million shares as on 2025-03-31, resulting in a short ratio of 0.72. According to the data, the short interest in Spruce Biosciences Inc (SPRB) stood at 35.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.43 million. The stock has fallen by -70.71% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SPRB stock heading into the next quarter.
